Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021

doi:10.1007/s00384-024-04711-x

科研成果详情

题名	Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021
作者	Lin, Daopo1,2; Jin, Yang1,2; Shao, Xiaoxiao1,2; Xu, Yuan 1,2; Ma, Guolong1,2; Jiang, Yi1,2; Xu, Yinghe3; Jiang, Yongpo3; Hu, Dingyuan1,2
发表日期	2024-09-07
发表期刊	International Journal of Colorectal Disease 影响因子和分区
语种	英语
原始文献类型	Article
关键词	Inflammatory bowel disease Epidemiology Global Burden of Diseases
其他关键词	CROHNS-DISEASE ; RISK-FACTORS ; POPULATION ; CHINA
摘要	PurposeThe prevalence of inflammatory bowel disease (IBD) is on the rise worldwide. We utilizes data from the Global Burden of Diseases (GBD) 2021 to analyze the national-level burden of IBD, trends in disease incidence, and epidemiological characteristics.MethodsDetailed information on IBD was gathered from 204 countries and territories spanning 1990 to 2021, sourced from the GBD 2021. Calculations were performed for incidence rates, mortality rates, disease-adjusted life years (DALYs), and estimated annual percentage changes (EAPCs). These trends were analyzed based on region, nationality, age, gender, and World Bank income level stratifications.ResultsThe global age-standardised incident rate (ASIR) of IBD increased from 4.22 per 100000 in 1990 to 4.45 per 100000 in 2021. However, the age-standardised mortality rate (ASMR) decreased from 0.60 per 100000 in 1990 to 0.52 per 100000 in 2021. Similarly, the age-standardised DALYs rate decreased from 21.55 per 100000 in 1990 to 18.07 per 100000 in 2021. Gender comparisons showed negligible differences in disease burden. The greatest increase in IBD-associated ASIR and ASMR occurred in World Bank upper-middle income region (EAPCs, 1.25) and World Bank high-income region (EAPCs, 1.00), respectively. Regionally, East Asia experienced the largest increase in ASIR (EAPCs, 2.89). Among 204 countries, China had the greatest increases in ASIR (EAPCs, 2.93), Netherlands had the highest ASMR in 2021 (2.21 per 100000).ConclusionsGlobal incidence rate of IBD have been increasing from 1990 to 2021, while the DALYs and mortality have been decreasing. The escalating incident rates in select Asian regions deserves further attention.
资助项目	Zhejiang Provincial Natural Science Foundation
出版者	SPRINGER
ISSN	0179-1958
EISSN	1432-1262
卷号	39 期号:1
DOI	10.1007/s00384-024-04711-x
页数	9
WOS类目	Gastroenterology & Hepatology ; Surgery
WOS研究方向	Gastroenterology & Hepatology ; Surgery
WOS记录号	WOS:001308299000001
收录类别	SCIE ; SCOPUS ; PUBMED
URL	查看原文
PubMed ID	39243331
SCOPUSEID	2-s2.0-85203264411
通讯作者地址	[Hu, Dingyuan]Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China. ; [Hu, Dingyuan]Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China. ; [Xu, Yinghe;Jiang, Yongpo]Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Crit Care Med, Taizhou, Zhejiang, Peoples R China.
Scopus学科分类	Gastroenterology
SCOPUS_ID	SCOPUS_ID:85203264411
引用统计
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/218737
专题	附属第二医院附属第二医院_消化内科第二临床医学院、附属第二医院、育英儿童医院附属台州医院其他_附属台州医院（浙江省台州医院）
通讯作者	Xu, Yinghe; Jiang, Yongpo; Hu, Dingyuan
作者单位	1.Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; 2.Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; 3.Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Crit Care Med, Taizhou, Zhejiang, Peoples R China
第一作者单位	附属第二医院; 第二临床医学院，附属第二医院、育英儿童医院; 消化内科
通讯作者单位	附属第二医院; 第二临床医学院，附属第二医院、育英儿童医院; 消化内科; 附属台州医院（浙江省台州医院）; 附属台州医院
第一作者的第一单位	附属第二医院
推荐引用方式 GB/T 7714	Lin, Daopo,Jin, Yang,Shao, Xiaoxiao,et al. Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021[J]. International Journal of Colorectal Disease,2024,39(1).
APA	Lin, Daopo., Jin, Yang., Shao, Xiaoxiao., Xu, Yuan., Ma, Guolong., ... & Hu, Dingyuan. (2024). Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021. International Journal of Colorectal Disease, 39(1).
MLA	Lin, Daopo,et al."Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021".International Journal of Colorectal Disease 39.1(2024).